These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 2151369

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Influence of tamoxifen-medroxyprogesterone sequential therapy on estrogen and progesterone receptor contents of breast cancer.
    Noguchi S, Yamamoto H, Inaji H, Imaoka S, Koyama H.
    Jpn J Cancer Res; 1989 Mar; 80(3):244-8. PubMed ID: 2524460
    [Abstract] [Full Text] [Related]

  • 3. Alternating sequential endocrine therapy: tamoxifen and medroxyprogesterone acetate versus tamoxifen in postmenopausal advanced breast cancer patients.
    Beltrán M, Alonso MC, Ojeda MB, Izquierdo A, Ferrer J, Picó C, Anglada L, Catalán G, Batiste-Alentorn E, Tusquets I.
    Ann Oncol; 1991 Jul; 2(7):495-9. PubMed ID: 1832944
    [Abstract] [Full Text] [Related]

  • 4. Sequential alternate administration of tamoxifen and medroxyprogesterone acetate in advanced breast cancer: clinical-biological randomized study.
    De Lena M, Tommasi S, Schittulli F, Lorusso V, Paradiso A.
    Tumori; 1990 Apr 30; 76(2):190-5. PubMed ID: 2139523
    [Abstract] [Full Text] [Related]

  • 5. Therapeutic effect of tamoxifen alone versus tamoxifen in combination wtih gestagen and oestrogen in advanced breast cancer.
    Mouridsen HT, Palshof T, Rose C.
    Recent Results Cancer Res; 1980 Apr 30; 71():169-77. PubMed ID: 6988913
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Oral high-dose medroxyprogesterone acetate versus tamoxifen. A randomized crossover trial in postmenopausal patients with advanced breast cancer.
    van Veelen H, Willemse PH, Tjabbes T, Schweitzer MJ, Sleijfer DT.
    Cancer; 1986 Jul 01; 58(1):7-13. PubMed ID: 2939943
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Endocrine therapy testing of human breast cancers in the soft agar clonogenic assay.
    Osborne CK, Von Hoff DD, Mullins K.
    Breast Cancer Res Treat; 1985 Jul 01; 6(3):229-35. PubMed ID: 2936413
    [Abstract] [Full Text] [Related]

  • 13. [Effects of estrogen and endocrine therapeutic agents on the estrogen receptor, progesterone receptor and DNA synthesis in MCF-7 human breast cancer cells using the whole cell uptake method].
    Kurebayashi J, Horiuchi R, Nakamura T, Iino Y, Ishida T, Takigawa H, Izuo M.
    Nihon Naibunpi Gakkai Zasshi; 1987 Nov 20; 63(11):1351-63. PubMed ID: 2965035
    [Abstract] [Full Text] [Related]

  • 14. Chemotherapy with or without high-dose medroxyprogesterone acetate in oestrogen-receptor-negative advanced breast cancer. Norwegian Breast Cancer Group.
    Gundersen S, Kvinnsland S, Klepp O, Lund E, Hannisdal E, Høst H.
    Eur J Cancer; 1992 Nov 20; 28(2-3):390-4. PubMed ID: 1534248
    [Abstract] [Full Text] [Related]

  • 15. [Results of tamoxifen-medroxyprogesterone acetate sequential therapy in 22 patients with recurrent breast cancer].
    Noguchi S, Yamamoto H, Inaii H, Koyama H.
    Gan To Kagaku Ryoho; 1989 Nov 20; 16(11):3555-8. PubMed ID: 2530936
    [Abstract] [Full Text] [Related]

  • 16. Cyclic and sequential therapy with tamoxifen and medroxyprogesterone acetate in metastatic breast cancer.
    Nemoto T, Patel JK, Rosner D, Dao TL, Halvorson H.
    J Surg Oncol; 1989 Aug 20; 41(4):226-9. PubMed ID: 2526907
    [Abstract] [Full Text] [Related]

  • 17. Therapeutic effect of tamoxifen related to estrogen receptor level.
    Rose C, Thorpe SM, Løber J, Daenfeldt JL, Palshof T, Mouridsen HT.
    Recent Results Cancer Res; 1980 Aug 20; 71():134-41. PubMed ID: 6988911
    [Abstract] [Full Text] [Related]

  • 18. [Metastatic breast cancer: a comparative study of the efficacy of tamoxifen and the sequential administration of tamoxifen and medroxyprogesterone acetate].
    Giralt E, Jouve M, Palangie T, Bretaudeau B, Asselain B, Magdelenat H, Merle S, Zajdela A, Pouillart P.
    Bull Cancer; 1984 Aug 20; 71(1):22-9. PubMed ID: 6324934
    [Abstract] [Full Text] [Related]

  • 19. Effective sequential administration of tamoxifen and medroxyprogesterone acetate for 7,12-dimethylbenz[a-anthracene-induced rat mammary tumors in relation to hormone receptors.
    Tominaga T, Yoshida Y, Kitamura M, Kosaki G.
    Jpn J Cancer Res; 1985 Nov 20; 76(11):1120-5. PubMed ID: 2935517
    [Abstract] [Full Text] [Related]

  • 20. Medroxyprogesterone acetate versus tamoxifen in the therapy of advanced breast cancer.
    Lorenz I, Mechl Z.
    Neoplasma; 1985 Nov 20; 32(1):119-24. PubMed ID: 3157070
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.